In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

Geron Corporation's RYTELO gains FDA approval for Low-Risk MDS, with strong sales projections and promising Phase 3 study.

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...

Let’s talk iron. While pumping iron is one of many athletic pursuits, it doesn’t go well when your body’s iron stores are ...

For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat ...

To better understand the benefits and risks associated with lymphatic drainage massages, we got the inside scoop from Rebecca ...

Good, R. A., Gabrielsen, A. E., Peterson, R. D. A., and Cooper, M. D., Trans. and Studies of the College of Physicians of Philadelphia, 33, 180 (1966). Cooper, M. D ...

Whitney Ijem, an analyst from Canaccord Genuity, maintained the Buy rating on Generation Bio (GBIO – Research Report). The associated price ...

Kala-azar or visceral leishmaniasis, a deadly neglected tropical disease, can be better treated using a compound derived from ...

A compound derived from Nectandra leucantha, a tree native to southern Brazil (local names: canela-seca or canela-branca), ...